Web Stats Provided By Google Analytics

Thursday, January 23, 2014

GeoVax Announces Publication of Phase 2a Clinical Trial in The Journal of Infectious Diseases

The article, titled "Specificity and Six-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles" was published on-line in The Journal of Infectious Diseases.

http://ift.tt/1eFbxfe

No comments:

Post a Comment